Conditions: Anemia; Esophageal Cancer; Gastric Cancer
Intervention: Drug: Iron isomaltoside 1000
Sponsors: Nottingham University Hospitals NHS Trust; Pharmacosmos A/S
Recruiting - verified October 2016
http://ift.tt/2eOJouM
http://ift.tt/2dTmH3O
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Severe bone atrophy jeopardizes the success of endosseous implants. This technical note aims to present the innovative concept of additively...
-
http://ift.tt/2rxojYy http://ift.tt/2sQ9Tqw
-
The Role of KIT Mutations in Anaphylaxis Abstract Purpose of Review Gain of function KIT mutations are detected in clonal mast cell diseases...
-
Solid Pseudopapillary Neoplasms of the Pancreas: Clinicopathologic and Radiologic Features According... Solid Pseudopapillary Neoplasms of t...
-
New Recommendations for the Treatment of Differentiated Thyroid Cancer : This Viewpoint assesses the treatment options for differen...
-
Molecules, Vol. 24, Pages 2837: Bioavailability and Bioactivity of Encapsulated Phenolics and Carotenoids Isolated from Red Pepper Waste Mol...
-
from #ΓεύσηΌσφρηση via xlomafota13 on Inoreader http://ift.tt/1p2G54J
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου